Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00580489 · ClinicalTrials.gov registry record · NA

Lifeflight: Fentanyl Versus Morphine

A NA study, sponsored by MetroHealth Medical Center.

Completed
Registry status
NA
Development phase
204
Enrollment target

NCT00580489 is a NA study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 204 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00580489, a NA study, has completed, sponsored by MetroHealth Medical Center.

COMPLETED
Registry status
NA
Development phase
204 participants
Enrollment target

Study Summary

The study is exempt from informed consent by the MetroHealth Medical Center institutional review board (IRB), because two standards of care are used and there is no increased clinical risk to the patient due to the study. The researchers randomize either fentanyl or morphine to be given to trauma patients and record how their pain scale is treated along with observing for adverse events. They are looking to see if the hypothesized benefits of fentanyl (which is much more expensive than morphine) actually exist.

Interventions

  • DRUG either fentanyl or morphine

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2006-08
Est. Completion 2008-12
Phase NA

Sponsor

MetroHealth Medical Center

76 total trials

What the Registry Record Tells You About NCT00580489

The ClinicalTrials.gov registry entry for NCT00580489 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which either fentanyl or morphine is the first listed.

NCT00580489 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00580489 about?

NCT00580489 is a clinical study titled "Lifeflight: Fentanyl Versus Morphine". The study is exempt from informed consent by the MetroHealth Medical Center institutional review board (IRB), because two standards of care are used and there is no increased clinical risk to the patient due to the study. The researchers randomize either fentanyl or morphine to be given to trauma pa...

What is the current status of trial NCT00580489?

This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2006-08. Estimated completion is 2008-12.

What interventions are being tested in trial NCT00580489?

The interventions under investigation include: either fentanyl or morphine (DRUG).

Who is sponsoring clinical trial NCT00580489?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.